178 related articles for article (PubMed ID: 15930335)
1. Critical role of peroxisome proliferator-activated receptor gamma on anoikis and invasion of squamous cell carcinoma.
Masuda T; Wada K; Nakajima A; Okura M; Kudo C; Kadowaki T; Kogo M; Kamisaki Y
Clin Cancer Res; 2005 Jun; 11(11):4012-21. PubMed ID: 15930335
[TBL] [Abstract][Full Text] [Related]
2. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma.
Kusayama M; Wada K; Nagata M; Ishimoto S; Takahashi H; Yoneda M; Nakajima A; Okura M; Kogo M; Kamisaki Y
Cancer Sci; 2011 Jun; 102(6):1128-36. PubMed ID: 21401805
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
Schaefer KL; Wada K; Takahashi H; Matsuhashi N; Ohnishi S; Wolfe MM; Turner JR; Nakajima A; Borkan SC; Saubermann LJ
Cancer Res; 2005 Mar; 65(6):2251-9. PubMed ID: 15781638
[TBL] [Abstract][Full Text] [Related]
4. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
5. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
Kamarajan P; Kapila YL
Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
[TBL] [Abstract][Full Text] [Related]
6. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma.
Ishida H; Wada K; Masuda T; Okura M; Kohama K; Sano Y; Nakajima A; Kogo M; Kamisaki Y
Cancer Sci; 2007 May; 98(5):636-43. PubMed ID: 17355262
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness.
Celetti A; Testa D; Staibano S; Merolla F; Guarino V; Castellone MD; Iovine R; Mansueto G; Somma P; De Rosa G; Galli V; Melillo RM; Santoro M
Clin Cancer Res; 2005 Nov; 11(22):8019-27. PubMed ID: 16299231
[TBL] [Abstract][Full Text] [Related]
9. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
[TBL] [Abstract][Full Text] [Related]
10. The PPARgamma antagonist T0070907 suppresses breast cancer cell proliferation and motility via both PPARgamma-dependent and -independent mechanisms.
Zaytseva YY; Wallis NK; Southard RC; Kilgore MW
Anticancer Res; 2011 Mar; 31(3):813-23. PubMed ID: 21498701
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of peroxisome proliferator-activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties.
Takahashi H; Fujita K; Fujisawa T; Yonemitsu K; Tomimoto A; Ikeda I; Yoneda M; Masuda T; Schaefer K; Saubermann LJ; Shimamura T; Saitoh S; Tachibana M; Wada K; Nakagama H; Nakajima A
Cancer Sci; 2006 Sep; 97(9):854-60. PubMed ID: 16805824
[TBL] [Abstract][Full Text] [Related]
12. [15-deoxy-Delta(12,14)-prostaglandin J(2) induces anoikis of hepatocellular carcinoma cells: an in vitro experiment].
Cao LQ; Wang Q; Chen XL; Zhen MC; Fu XH; Huang XH
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):3001-5. PubMed ID: 18261336
[TBL] [Abstract][Full Text] [Related]
13. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
[TBL] [Abstract][Full Text] [Related]
14. Absence of adhesion triggers differential FAK and SAPKp38 signals in SW620 human colon cancer cells that may inhibit adhesiveness and lead to cell death.
Walsh MF; Thamilselvan V; Grotelueschen R; Farhana L; Basson M
Cell Physiol Biochem; 2003; 13(3):135-46. PubMed ID: 12876384
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cells.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Surgery; 2004 May; 135(5):555-62. PubMed ID: 15118593
[TBL] [Abstract][Full Text] [Related]
16. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma.
Wang XC; Wu YP; Ye B; Lin DC; Feng YB; Zhang ZQ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
Mol Cancer Res; 2009 Jan; 7(1):12-22. PubMed ID: 19147533
[TBL] [Abstract][Full Text] [Related]
17. The C-terminal domain of focal adhesion kinase reduces the tumor cell invasiveness in chondrosarcoma cell lines.
Lee JW; Hee Kim Y; Boong Park H; Xu LH; Cance WG; Block JA; Scully SP
J Orthop Res; 2003 Nov; 21(6):1071-80. PubMed ID: 14554221
[TBL] [Abstract][Full Text] [Related]
18. Elevated focal adhesion kinase expression facilitates oral tumor cell invasion.
Schneider GB; Kurago Z; Zaharias R; Gruman LM; Schaller MD; Hendrix MJ
Cancer; 2002 Dec; 95(12):2508-15. PubMed ID: 12467064
[TBL] [Abstract][Full Text] [Related]
19. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma.
Ota K; Ito K; Suzuki T; Saito S; Tamura M; Hayashi S; Okamura K; Sasano H; Yaegashi N
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4200-8. PubMed ID: 16857792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
